Thrombopoietin Levels and Platelet Transfusion in Neonates
NCT00549484 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20
Last updated 2008-01-18
Summary
Infants who have low platelets and who require a platelet transfusion are included in this study. Platelet transfusions are routinely given to infants when their platelet count falls below a certain level. The study will look at the amount of platelets transfused. The purpose of the study is to evaluate the effect of platelet transfusions on the level of a protein (thrombopoietin) which is known to help control platelet production.
Conditions
Sponsors & Collaborators
-
Christiana Care Health Services
lead OTHER
Principal Investigators
-
Alex Kline, MD · Christiana Hospital
-
David A. Paul, MD · Christiana Hospital
Eligibility
- Max Age
- 6 Months
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2003-05-31
- Primary Completion
- 2004-09-30
- Completion
- 2004-09-30
Countries
- United States
Study Locations
More Related Trials
-
A Prospective, One-arm and Open Clinical Study of Obinutuzumab in the Treatment of Pediatric Primary Immune Thrombocytopenia (ITP)
NCT06094881 ·Status: RECRUITING ·Phase: PHASE2
-
Diagnostic of Chronic Thrombocytopenia
NCT04071496 ·Status: COMPLETED
-
Avatrombopag for the Treatment of Thrombocytopenia in Pediatric Subjects With Immune Thrombocytopenia for ≥6 Months
NCT04516967 ·Status: COMPLETED ·Phase: PHASE3
-
Recombinant Human Thrombopoietin(rhTPO) in Pregnancy With Immune Thrombocytopenia
NCT03492515 ·Status: UNKNOWN ·Phase: PHASE3
-
Study on the Anti-HPA Antibodies Caused Neonatal Alloimmune Thrombocytopenia in Chinese Pregnant Women
NCT02934906 ·Status: UNKNOWN
-
Phase I Study of Eltrombopag for Promoting Thrombopoiesis After Total Body Irradiation
NCT00903929 ·Status: COMPLETED ·Phase: PHASE1
-
Observational Study: Hetrombopag for Platelet Recovery in Haploidentical HSCT
NCT07003269 ·Status: ENROLLING_BY_INVITATION
-
A Study of Nipocalimab in Reducing the Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)
NCT06449651 ·Status: RECRUITING ·Phase: PHASE3
-
Safety of Oral Thrombopoietin Receptor Agonist in Pediatric Chronic ITP
NCT05846529 ·Status: UNKNOWN
-
Two Regimens of IVIG in the Treatment of Newly Diagnosed ITP in Children
NCT05520892 ·Status: RECRUITING ·Phase: PHASE4
-
Basket Study to Assess Efficacy, Safety and PK of Iptacopan (LNP023) in Autoimmune Benign Hematological Disorders
NCT05086744 ·Status: TERMINATED ·Phase: PHASE2
-
Bleeding Prediction in Thrombocytopenia
NCT02306044 ·Status: COMPLETED
-
Rate of Prolonged Response After Stopping Thrombopoietin-receptor Agonists Treatment in ITP
NCT03119974 ·Status: COMPLETED ·Phase: PHASE4
-
Longitudinal Cohort of Pediatric Primary Immune Thrombocytopenia (ITP)
NCT06107582 ·Status: RECRUITING
-
Eltrombopag for Post Transplant Thrombocytopenia
NCT01000051 ·Status: COMPLETED ·Phase: PHASE2
-
Association of Platelet Parameters With Bleeding Severity in Children With ITP
NCT03810352 ·Status: COMPLETED
-
Post IVIG Medication in Children With Immune Thrombocytopenia
NCT04741139 ·Status: UNKNOWN ·Phase: PHASE1
-
Dose Dense Rituximab for High Risk Newly Diagnosed Acute Immune Thrombocytopenic Purpura
NCT04323748 ·Status: RECRUITING ·Phase: PHASE1
-
Prospective Study of Patients With Thrombocytopenia Following HSCT
NCT02487563 ·Status: COMPLETED ·Phase: PHASE3
-
Anti-CD38 Antibody Treating Pediatric Primary Immune Thrombocytopenia (ITP)
NCT06168851 ·Status: RECRUITING ·Phase: PHASE2
-
Cohort of Children With Acute Immune or Idiopathic Thrombocytopenic Purpura (ITP) : a Prospective Study in Pays De La Loire
NCT00331357 ·Status: UNKNOWN
-
Treatment of Idiopathic Thrombocytopenic Purpura (ITP) With Subcutaneously Administered Anti-D
NCT00128882 ·Status: COMPLETED ·Phase: PHASE2
-
Study of a New Medication for Childhood Chronic Immune Thrombocytopenia (ITP), a Blood Disorder of Low Platelet Counts That Can Lead to Bruising Easily, Bleeding Gums, and/or Bleeding Inside the Body.
NCT01520909 ·Status: COMPLETED ·Phase: PHASE3
-
An Epidemiological Study of Subjects With Immune Thrombocytopenic Purpura to Evaluate the Relationship Between Platelet Counts, Endogenous Thrombopoietin Levels, Endogenous Anti-Thrombopoietin Antibodies, and Selected Autoimmune Markers
NCT00005570 ·Status: COMPLETED
-
Defibrotide TMA Prophylaxis Pilot Trial
NCT03384693 ·Status: COMPLETED ·Phase: PHASE2